Nettles William Benjamin JR 4

4 · BED BATH & BEYOND, INC. · Filed May 18, 2026

AI-generated summary of this filing

Updated May 18, 2026

Bed Bath & Beyond (BBBY) Director William Nettles Receives RSUs, Converts Units

What Happened

William Benjamin Nettles, Jr., a director of Bed Bath & Beyond, was granted 35,181 restricted stock units (RSUs) on May 14, 2026 (reported as a $0.00 award). On May 15, 2026, 26,873 derivative units vested and were converted/exercised (reported as acquired); the filing also reports a contemporaneous disposition of 26,873 units at $0.00. The filing also records a prior distribution of 2,286 warrants (from October 7, 2025). No cash prices or dollar values were reported for the conversions or dispositions in this Form 4.

Key Details

Transaction dates and types:
- 2026-05-14: Grant/award — 35,181 RSUs @ $0.00 (unvested; see footnote F2).
- 2026-05-15: Exercise/conversion — 26,873 units acquired (conversion of vested RSUs; footnote F1).
- 2026-05-15: Exercise/conversion — 26,873 units disposed @ $0.00 (same day, per filing).
- 2025-10-07: Grant — 2,286 warrants (pro-rata distribution; footnote F3).
Shares/units reported after the transactions: the filing shows the 35,181 RSUs from the May 14 grant (unvested, vesting 5/14/2027 per F2) and the previously issued 2,286 warrants; the 26,873 units that vested on 5/15/2026 were converted and reported as disposed in the filing.
Notable footnotes:
- F1: The 26,873 RSUs vested on 5/15/2026 and vested shares are delivered promptly after vesting.
- F2: The 35,181 RSUs granted 5/14/2026 vest 5/14/2027.
- F3: The 2,286 items from 10/7/2025 are warrants (each exercisable for one share at $15.50), originally distributed pro rata.
Timeliness: Form 4 was filed on 2026-05-18 for transactions on 5/14–5/15/2026. This filing date is within the standard SEC Form 4 reporting window (filed promptly after the transactions) and is not marked late.

Context

RSUs are derivative awards that convert into common shares upon vesting; F1 confirms these RSUs vested and were converted on 5/15/2026. The filing reports both acquisition (conversion) and a same-day disposition of the converted units at $0.00; the Form 4 does not provide a reason for the $0.00 disposition.
These entries are award/vesting and conversion events rather than open-market purchases or sales; award grants and vesting are routine forms of executive compensation and do not by themselves indicate the insider’s market view.

Form 4

Period: 2026-05-14

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-05-15+26,873→ 49,747 total
Award
Restricted Stock Units
[F2]
2026-05-14+35,181→ 35,181 total
→ Common Stock (35,181 underlying)
Exercise/Conversion
Restricted Stock Units
[F1]
2026-05-15−26,873→ 0 total
→ Common Stock (26,873 underlying)
Award
Common Stock Warrant
[F3]
2025-10-07+2,286→ 2,286 total
Exercise: $15.50From: 2025-12-03Exp: 2026-10-07→ Common Stock (2,286 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vested at the close of business on May 15, 2026. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
[F2]Each restricted stock unit represents a contingent right to receive one share of Bed Bath & Beyond, Inc. common stock. The restricted stock units vest at the close of business on May 14, 2027. Vested shares are delivered to the reporting person promptly after the restricted stock units vest. Amounts shown reflect restricted stock units from the subject grant beneficially owned following the transaction reported herein.
[F3]Represents warrants that were originally issued on October 7, 2025 as a pro-rata distribution to all holders of common stock. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $15.50 per warrant. This distribution was exempt from immediate reporting under Section 16.

Signature

/s/ Christina Wheeler, Attorney-in-Fact|2026-05-18

1 file